Submitted by Anonymous (not verified) on 24 February 2026 - 16:12
Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrastim, Date of authorisation: 18/08/2025, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrastim, Date of authorisation: 18/08/2025, Revision: 1, Status: Authorised